Skip to main content

Table 1 The genome-wide expression profiles of CRC patients used in this study

From: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer

Datasets

#GEO

Samples

TCGA-COAD

GDC

478 cancer and 41 normal samples

TCGA-READ

GDC

166 cancer and 10 normal samples

Reumers et al.

GSE117606

65 normal, 59 adenoma and 74 tumors

Kim et al.

GSE50760

18 normal, 18 tumor and 18 metastasis patients

Sheffer et al.

GSE41258

54 normal, 186 tumor, 47 liver and 20 lung metastasis patients

Marra et al.

GSE8671

32 normal and 32 tumors

Uddin et al.

GSE23878

24 normal and 35 tumors

Skrzypczak et al.

GSE20916

34 normal, 45 adenoma and 36 adenocarcinoma

Matsuyama et al.

GSE18105

17 normal, 17 tumor and 77 laser-capture microdissection patients

Smith et al.

GSE17536

177 patient with overall survival and disease-free survival

Jorissen et al.

GSE14333

226 patients with survival time